Trulieve Cannabis (NYSE: TRLV) revenue
Trulieve Cannabis reported revenue of $1,181m for fiscal 2025, 0.4% less than in fiscal 2024 ($1,186m). Since fiscal 2020 its revenue has grown by 126.5%, an average growth of 17.8% a year.
Trulieve Cannabis's best year of the last 6 was fiscal 2022. The biggest drop was in fiscal 2023, −7.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,181m | −0.4% | $143.5m | 12.1% |
| 2024 | $1,186m | +5.1% | $97.8m | 8.2% |
| 2023 | $1,129m | −7.3% | −$221.6m | −19.6% |
| 2022 | $1,218m | +30.7% | $50.2m | 4.1% |
| 2021 | $931.9m | +78.7% | $204.1m | 21.9% |
| 2020 | $521.5m | — | $218.3m | 41.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Trulieve Cannabis revenue compared with its sector
By revenue for its latest fiscal year, Trulieve Cannabis ranks 141st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Trulieve Cannabis, −0.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 139th | Bio-Techne | $1,215m | −0.4% |
| 140th | Omnicell | $1,185m | 6.5% |
| 141st | Trulieve Cannabis | $1,181m | −0.4% |
| 142nd | Sotera Health | $1,164m | 5.7% |
| 143rd | Novavax | $1,123m | 64.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Trulieve Cannabis
- How much revenue did Trulieve Cannabis make in fiscal 2025?
- Trulieve Cannabis reported revenue of $1,181m for fiscal 2025, compared with $1,186m in fiscal 2024.
- How much has the revenue of Trulieve Cannabis grown?
- Between fiscal 2020 and fiscal 2025 it went from $521.5m to $1,181m: 126.5% more, an average growth of 17.8% a year.
- What was the best year for revenue at Trulieve Cannabis?
- Of its last 6 fiscal years, fiscal 2022, with $1,218m.
- Where does Trulieve Cannabis rank in its sector by revenue?
- It ranks 141st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Trulieve Cannabis come from?
- From the annual report (Form 10-K) that Trulieve Cannabis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Trulieve Cannabis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Trulieve Cannabis: the Trulieve Cannabis page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.